Stay updated on Phase 2 AMEERA-4 Clinical Trial
Sign up to get notified when there's something new on the Phase 2 AMEERA-4 Clinical Trial page.

Latest updates to the Phase 2 AMEERA-4 Clinical Trial page
- Check4 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check33 days agoChange DetectedSite framework updated from v3.4.3 to v3.5.0. This upgrade updates the underlying templates and UI components used to render pages.SummaryDifference0.0%

- Check40 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3. This change does not affect study content or page functionality.SummaryDifference0.0%

- Check69 days agoChange DetectedThe site revision label was updated from v3.4.1 to v3.4.2; no changes to study details or page behavior are visible.SummaryDifference0.0%

- Check76 days agoChange DetectedThe page now displays Revision: v3.4.1, replacing the previous Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check83 days agoChange DetectedGlossary display is now visible on the page, and the revision tag has been updated to v3.4.0. The QC criteria and FEAR Act-related labels have been updated: 'Last Update Submitted that Met QC Criteria' was added and 'Last Update Submitted that met QC Criteria' removed, while 'No FEAR Act Data' was added and 'No FEAR Act data' removed.SummaryDifference0.2%

Stay in the know with updates to Phase 2 AMEERA-4 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 2 AMEERA-4 Clinical Trial page.